Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
NCT06105411 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2025-09-05
Summary
This trial will demonstrate localised uptake of a radiolabelled fungal component (siderophore) in areas of known specific invasive fungal (Aspergillus) infection.
Conditions
- Invasive Fungal Infections
Interventions
- DIAGNOSTIC_TEST
-
68Ga-labelled TAFC PET/CT scan
68Ga-labelled TAFC PET/CT scan (whole body)
Sponsors & Collaborators
-
Peter MacCallum Cancer Centre, Australia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-01
- Primary Completion
- 2026-10-31
- Completion
- 2027-04-30
Countries
- Australia
Study Locations
More Related Trials
-
PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome.
NCT03121235 ·Status: COMPLETED
-
Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease
NCT01499433 ·Status: UNKNOWN ·Phase: PHASE4
-
Diagnostic and Management Strategies for Invasive Aspergillosis
NCT00816088 ·Status: COMPLETED
-
Micafungin Salvage Mono-therapy in Invasive Aspergillosis
NCT00376337 ·Status: TERMINATED ·Phase: PHASE2
-
Early Diagnosis of Invasive Lung Aspergillosis
NCT05860387 ·Status: RECRUITING
-
Treatment Duration of IPA
NCT06583512 ·Status: ACTIVE_NOT_RECRUITING
-
Assessment of Volatile Organic Compounds (VOC) for the Diagnosis of Invasive Aspergillosis (IA) in Lung Transplant Recipients
NCT06344117 ·Status: RECRUITING
-
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis
NCT01916057 ·Status: COMPLETED ·Phase: NA
-
MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)
NCT00076869 ·Status: COMPLETED ·Phase: PHASE2
-
ATCF (Azole Therapy in Cystic Fibrosis)
NCT01576315 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
NCT00003031 ·Status: COMPLETED ·Phase: PHASE3
-
Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung Transplant
NCT03561415 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease
NCT06819410 ·Status: RECRUITING
-
Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
NCT00238355 ·Status: TERMINATED ·Phase: PHASE2
-
Invasive Fungal Infections Surveillance Initiative
NCT00177944 ·Status: COMPLETED
-
Clinical Trial of Pulmonary Cryptococcosis in China
NCT02503449 ·Status: UNKNOWN
-
Identification of Bacterial and Fungal Isolates in Patients with Sinonasal Polyps
NCT06637449 ·Status: NOT_YET_RECRUITING
-
Isavuconazole in Critically Ill Patients: Efficacy and Safety
NCT07080359 ·Status: NOT_YET_RECRUITING
-
Study of FK463 for the Treatment of Invasive Aspergillosis
NCT00036166 ·Status: COMPLETED ·Phase: PHASE2
-
PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic Value
NCT07313527 ·Status: RECRUITING
-
Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis
NCT00528190 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Intrabronchial Voriconazole Instillation for Inoperable Pulmonary Aspergilloma
NCT03799809 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)
NCT00620074 ·Status: TERMINATED ·Phase: PHASE4
-
Itraconazole Therapy In Bronchiectasis With Airway Mold
NCT07283497 ·Status: RECRUITING ·Phase: PHASE4
-
An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections
NCT01823289 ·Status: COMPLETED ·Phase: PHASE4